Simcere Pharmaceutical Group - Product Pipeline Review - 2016

  • ID: 3641079
  • Company Profile
  • 53 pages
  • Global Markets Direct
1 of 4
Simcere Pharmaceutical Group - Product Pipeline Review - 2016

Summary

‘Simcere Pharmaceutical Group - Product Pipeline Review - 2016’, provides an overview of the Simcere Pharmaceutical Group’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Simcere Pharmaceutical Group, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Simcere Pharmaceutical Group
- The report provides overview of Simcere Pharmaceutical Group including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Simcere Pharmaceutical Group’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Simcere Pharmaceutical Group’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Simcere Pharmaceutical Group’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Simcere Pharmaceutical Group
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Simcere Pharmaceutical Group’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Simcere Pharmaceutical Group Snapshot

Simcere Pharmaceutical Group Overview

Key Information

Key Facts

Simcere Pharmaceutical Group - Research and Development Overview

Key Therapeutic Areas

Simcere Pharmaceutical Group - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Simcere Pharmaceutical Group - Pipeline Products Glance

Simcere Pharmaceutical Group - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

Simcere Pharmaceutical Group - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Simcere Pharmaceutical Group - Early Stage Pipeline Products

IND/CTA Filed Products/Combination Treatment Modalities

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Simcere Pharmaceutical Group - Drug Profiles

SIM-071201

Product Description

Mechanism of Action

R&D Progress

bendamustine hydrochloride

Product Description

Mechanism of Action

R&D Progress

(amlodipine besylate + irbesartan)

Product Description

Mechanism of Action

R&D Progress

APX-003

Product Description

Mechanism of Action

R&D Progress

metatinib tromethamine

Product Description

Mechanism of Action

R&D Progress

abatacept

Product Description

Mechanism of Action

R&D Progress

BMS-817378

Product Description

Mechanism of Action

R&D Progress

OSI-930

Product Description

Mechanism of Action

R&D Progress

SIM-010603

Product Description

Mechanism of Action

R&D Progress

SIM-0710

Product Description

Mechanism of Action

R&D Progress

BMS-795311

Product Description

Mechanism of Action

R&D Progress

SCR-1693

Product Description

Mechanism of Action

R&D Progress

SIM-89

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Bruton's Tyrosine Kinase for Arthritis

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Cancer

Product Description

Mechanism of Action

R&D Progress

Simcere Pharmaceutical Group - Pipeline Analysis

Simcere Pharmaceutical Group - Pipeline Products by Target

Simcere Pharmaceutical Group - Pipeline Products by Route of Administration

Simcere Pharmaceutical Group - Pipeline Products by Molecule Type

Simcere Pharmaceutical Group - Pipeline Products by Mechanism of Action

Simcere Pharmaceutical Group - Recent Pipeline Updates

Simcere Pharmaceutical Group - Dormant Projects

Simcere Pharmaceutical Group - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Simcere Pharmaceutical Group, Key Information

Simcere Pharmaceutical Group, Key Facts

Simcere Pharmaceutical Group - Pipeline by Indication, 2016

Simcere Pharmaceutical Group - Pipeline by Stage of Development, 2016

Simcere Pharmaceutical Group - Monotherapy Products in Pipeline, 2016

Simcere Pharmaceutical Group - Combination Treatment Modalities in Pipeline, 2016

Simcere Pharmaceutical Group - Partnered Products in Pipeline, 2016

Simcere Pharmaceutical Group - Partnered Products/ Combination Treatment Modalities, 2016

Simcere Pharmaceutical Group - Phase III, 2016

Simcere Pharmaceutical Group - Phase II, 2016

Simcere Pharmaceutical Group - Phase I, 2016

Simcere Pharmaceutical Group - IND/CTA Filed, 2016

Simcere Pharmaceutical Group - Preclinical, 2016

Simcere Pharmaceutical Group - Discovery, 2016

Simcere Pharmaceutical Group - Pipeline by Target, 2016

Simcere Pharmaceutical Group - Pipeline by Route of Administration, 2016

Simcere Pharmaceutical Group - Pipeline by Molecule Type, 2016

Simcere Pharmaceutical Group - Pipeline Products by Mechanism of Action, 2016

Simcere Pharmaceutical Group - Recent Pipeline Updates, 2016

Simcere Pharmaceutical Group - Dormant Developmental Projects,2016

Simcere Pharmaceutical Group, Subsidiaries

List of Figures

Simcere Pharmaceutical Group - Pipeline by Top 10 Indication, 2016

Simcere Pharmaceutical Group - Pipeline by Stage of Development, 2016

Simcere Pharmaceutical Group - Monotherapy Products in Pipeline, 2016

Simcere Pharmaceutical Group - Partnered Products in Pipeline, 2016

Simcere Pharmaceutical Group - Pipeline by Top 10 Target, 2016

Simcere Pharmaceutical Group - Pipeline by Route of Administration, 2016

Simcere Pharmaceutical Group - Pipeline by Molecule Type, 2016

Simcere Pharmaceutical Group - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll